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Cutaneous squamous cell carcinoma (cSCC) is one of 
the leading causes of skin cancer mortality (1). The re-
cognition of, and stratification by, histological subtype is 
important in the prognostication of outcome. Follicular, 
or infundibulocystic, cSCC is a recently described sub-
type which is thought to arise from follicular cells and is 
estimated to account for approximately 1.3% of cSCC (2). 
Fewer than 90 cases have been reported, and this poorly 
understood form may be more common than previously 
thought (3). Hence the development of follicular cSCC 
in rare genetic conditions such as CYLD cutaneous syn-
drome (CCS) is informative and provides insights into 
tumour pathogenesis. Multiple familial trichoepitheliomas 
(MFT) is one of 3 phenotypes reported in CCS, and is 
associated with rare, germline mutations in CYLD (4). 
In this report we present a case of a follicular cSCC in a 
patient with the MFT phenotype. 
CASE REPORT
A 56-year-old woman presented with an ulcerated tumour on the 
dorsum of her left-hand (Fig. 1a). It had been increasing in size over 
the preceeding 4 months and was reported not to have arisen from 
a preexisting skin lesion. She had first presented in her teens with 
multiple facial papules that, after excision from her melolabial skin, 
were confirmed to be trichoepitheliomas. At the age of 53, a benign 
vulval cylindroma was excised. She had a history of significant 
UV exposure, having spent 4 months per year in Turkey for the 
past 10 years. She had two children, who both developed MFT in 
their teens, one of whom had been confirmed to have pathogenic 
mutation in CYLD (c.1112C>A). Skin examination of the patient 
revealed freckling and subtle poikiloderma consistent with her 
history of UV exposure. The tumour on the dorsum of her hand was 
a pink ulcerated nodule measuring 20 × 26 mm (Fig. 1A). The skin 
on her face had numerous, skin-coloured papules consistent with 
trichoepithelioma. No lesions were otherwise noted on the arms or 
torso. A punch biopsy of the nodule on the hand revealed features 
compatible with either trichofolliculoma or adnexal basal cell 
carcinoma. Clinicopathological correlation raised the suspicion of 
trichoblastic carcinoma or squamous cell carcinoma. As trichoblastic 
carcinoma has been reported to metastasize (5), a staging workup, 
including computerized tomography (CT) of the chest and abdomen 
was performed, and did not find evidence of systemic metastasis.
The tumour was then excised using Mohs micrographic surgery 
(MMS) and took 4 stages to clear, leaving a defect of 52 by 52 
mm. The debulk specimen showed poorly differentiated follicular 
cSCC, which was 6 mm thick and had an infiltrative growth pat-
tern (Fig. 1B). Positive Mohs stages, however, showed basaloid 
nests of immature palisading tumour cells in the dermis, consistent 
with trichofolliculoma (Fig. 1C). BerEp4 staining was negative in 
the debulk and positive in the Mohs stages (Fig. 1D). There was 
no evidence of recurrence or distant metastasis during a 3-year 
follow-up period. 
DISCUSSION
Follicular cSCC is a relatively uncommon subtype of cSCC 
that has only been recently recognised (3), and hence our 
finding of this tumour type on the genetic background 
of a germline CYLD mutation is of interest. The genetic 
mechanism underpinning this link is not yet clear. CYLD 
loss has been reported in sporadic human cSCC (6), and 
has been shown to increase cSCC invasion in mice. It is 
of interest that recently in oral squamous cell carcinoma, 
CYLD loss is seen as driving factor that facilitates in-
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Fig. 1. (a) Follicular squamous cell carcinoma (SCC). Ulcerated nodule 
measuring 20 x 26 mm on the left-hand dorsum growing faster and larger 
than her other lesions. (b) Poorly differentiated follicular cutaneous SCC 
on Mohs debulk specimen. (c) H+E of positive Mohs stage demonstrating 
features consistent with trichofolliculoma. (d) BerEp4 immunostaining of 
positive Mohs stage demonstrating increased expression at the infiltrative 
margin. (H+E: original magnification 10x; inset: 40x).
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vasion, via upregulation of TGF-Beta signalling (7), a 
pathway implicated in cSCC (8). We have not studied our 
sample for CYLD loss; however, given that CYLD loss 
is seen in cylindroma and spiradenoma, it is possible that 
it may play a role in the development of follicular cSCC.
Patients with CCS may present with 3 distinct but 
overlapping cutaneous phenotypes: MFT, where the pre-
dominant tumours are facial trichoepitheliomas, familial 
cylindromatosis (FC) where the predominant tumours are 
scalp cylindromas, and Brooke-Spiegler syndrome (BSS), 
where any combination of trichoepitheliomas, cylindro-
mas and related spiradenomas are seen (4). MFT, FC and 
BSS are all associated with mutations in CYLD, a tumour 
suppressor gene in which more than 100 mutations have 
been reported (9). The genetic factors that cause these 
different presentations are unknown, and all patterns can 
present in individuals from multigenerational families 
where the same CYLD mutation is seen (4). 
Cutaneous malignancy is an infrequent but recurrent 
feature in CCS, and hence monitoring is needed to detect 
clinically suspicious growing tumours. In patients with pre-
dominantly cylindromas and spiradenomas (FC and BSS), 
cylindrocarcinoma and spiradenocarcinoma are recognised 
to have a basal cell adenocarcinoma-like morphology and 
typically arise from benign pre-existing cylindroma and 
spiradenoma on biopsy (10). In patients with predomi-
nantly trichoepitheliomas, 3 patterns of malignancy are 
seen. MFT patients may develop pink papules which are 
basal cell carcinomas and these have been shown to arise 
in contiguity with trichoepithelioma, suggesting that trans-
formation is from pre-existing benign trichoepitheliomas, 
a feature corroborated by histology (11). Secondly, some 
patients have been reported to develop nodules which may 
be ulcerated, with histology relating to follicular carci-
noma, including trichoblastic carcinoma (5) or malignant 
hair matrix tumour (12). A third pattern has been outlined in 
recent reports, describing patients with larger lesions (3–5 
cm) that are ulcerated, rapidly growing and distinct from 
surrounding tumours. Histological reports from these larger 
tumours are consistent with a diagnosis of cSCC (13, 14). 
In one case, the tumour recurred despite repeated surgical 
excision and radiotherapy, resulting in the patient’s demise 
associated with intracranial invasion (14). Taken together 
with our case, these occurrences are difficult to dismiss 
as coincidental. It may be of clinical relevance that these 
reports are of patients from China and India (13, 14). White 
patients with European ancestry that have MFT typically 
develop small (< 1 cm) skin-coloured trichoepitheliomas 
(TEs) on the melolabial skin, forehead and chin. It has 
been previously observed in isolated reports that in patients 
from Asian and African genetic backgrounds, facial TEs 
may be much larger (4). Furthermore, confluent scalp 
cylindromas as seen in FC (historically termed “turban 
tumours”) have not been reported in patients with Asian 
and African ancestry. This could suggest that there may 
be genetic factors that influence tumour type and location 
in CSS that also impact on formation of cSCC. 
We report the novel finding of follicular cSCC in CCS, 
and the lack of recurrence 3 years after excision with 
MMS. Notably, it took 4 stages to achieve clear margins 
and it is likely that standard margins for excision would 
have resulted in incomplete excision. cSCC in CCS may 
have an adverse outcome, and as such, patients should be 
instructed to report tumours that are ulcerated, increasing 
in size or are visibly different to the benign tumours these 
patients develop for clinical and histological assessment. 
The morbidity associated with cSCC in these rare cases 
supports the use of MMS, as performed in our case.
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